![](/img/cover-not-exists.png)
Cost-Effectiveness of Losartan Versus Atenolol in Treating Hypertension—An Analysis of the LIFE Study from a Swiss Perspective
Thomas D. Szucs, Michel Burnier, Paul ErneVolume:
18
Language:
english
Pages:
7
DOI:
10.1007/s10557-005-5064-x
Date:
September, 2004
File:
PDF, 274 KB
english, 2004